Showing posts with label Gary Osborn. Show all posts
Showing posts with label Gary Osborn. Show all posts

Saturday, February 23, 2013

Apothecure's Voluntary Relinquishment in Florida, Reprimand from Texas, New Pharmacy at Same Address--Thank you Dr. Kenneth Woliner for the Research, Information and Your Comments


Here is Apothecure's voluntary relinquishment. (If anyone needs a copy that is easier to read, email me at stuckrichmond@gmail.com and I will email you the information).


APOTHECURE, INC
LICENSE NUMBER: PH21213Printer Friendly Version  


Profession
PHARMACY
License/Activity Status
DISCP-RELINQ/Click here for more information
Qualifications
Special Non-Resident
License Expiration DateLicense Original Issue Date
2/28/201503/28/2005
Discipline on FilePublic ComplaintClick here for more information
YES  Link To DisciplineYES  Link To Complaint
Address of Record
If further information is needed, please contact the Department of Health at (850) 488-0595.



Here is the "reprimand" Gary Osborn, the owner of Apothecure, got from Texas:  


Now that was before he plead guilty to violating the FFDCA, perhaps they'll go back and do something similar to what the Feds did against Thomas Bader of College Pharmacy (revoke his license, make him sell all his shares in the pharmacy to a non-family member): http://www.fda.gov/ICECI/CriminalInvestigations/ucm200282.htm (note well: his conviction was upheld, but the $4.8 million forfeiture was reversed due to an instructional error by the judge). 


Thursday, February 7, 2013

Washington Post Article: Compounding pharmacies have been linked to deaths, illnesses and safety failures for years

Founded in 2003, PharMEDium has four plants and annual sales of more than $100 million, officials said. The company says it uses only sterile, FDA-approved ingredients for the intravenous and epidural medications it supplies to more than 2,000 hospitals, including Johns Hopkins Hospital.
Company President Rich Kruzynski said the incidents are a fraction of the “tens of thousands of batches” provided to hospitals. The record, he said, demonstrates PharMEDium’s commitment to be the industry’s “gold standard” for quality, patient safety and regulatory compliance.
 
Continue reading here

Tuesday, November 27, 2012

State closes deadly drug shipment misbranding case


Published 2:00 p.m., Tuesday, November 27, 2012
AUSTIN, Texas (AP) — The Texas attorney general's office has resolved its case against a Dallas-based mail-order compounding pharmacy over a shipment of a misbranded drug ingredient blamed for three Pacific Northwest deaths.
An attorney general's office statement Tuesday says pharmacist Gary Osborn and his companies, Apothecure Inc. and SpectraPharm Inc., will pay $200,000 to the state, including $100,000 in civil penalties. They also agree to compound drugs to order and in a legal manner.
Osborn and ApotheCure received probation and $100,000 fines after pleading guilty to two misdemeanor criminal violations of the federal Food, Drug and Cosmetic Act.
The cases center on a February 2007 shipment of a gout drug containing some vials with dosages more than seven times stronger than shown on the label. Autopsies showed three Oregon patients suffered fatal overdoses.


Read more: http://www.sfgate.com/news/texas/article/State-closes-deadly-drug-shipment-misbranding-case-4071164.php#ixzz2DTGehD3Y

Monday, July 30, 2012

Recent Docket Entries in US v. Gary Osborn and Apothecure


07/06/2012 32 REPLY filed by USA as to Gary D Osborn, Apothecure Inc re: 28 MOTION Preclude Raising the Fine Ceiling Based on Judge-Found Facts (Claud, John) (Entered: 07/06/2012)
07/09/2012 33 MOTION for Leave to File Reply Brief filed by Gary D Osborn, Apothecure Inc (Attachments: # 1 Exhibit A) (Shields, Robert) (Entered: 07/09/2012)
07/09/2012 34 NOTICE of Intent to Travel Internationally as to Gary D Osborn. (Shields, Robert) Modified filers on 7/10/2012 (axm). (Entered: 07/09/2012)
07/10/2012 35 RESPONSE by USA as to Gary D Osborn, Apothecure Inc re: 33 MOTION for Leave to File Reply Brief (Claud, John) (Entered: 07/10/2012)
07/12/2012 36 ORDER granting 33 Motion for Leave to File Reply Brief as to Gary D Osborn (1), Apothecure Inc (2). Replies due by 7/20/2012. (Ordered by Judge Barbara M.G. Lynn on 7/12/2012) (cea) (Entered: 07/12/2012)
07/13/2012 37 REPLY filed by Gary D Osborn, Apothecure Inc re: 28 Motion to Preclude Raising the Fine Ceiling Based on Judge-Found Facts (Man, Christopher) Modified doc. linkage on 7/16/2012 (ctf). (Entered: 07/13/2012)
07/17/2012 38 NOTICE OF ATTORNEY APPEARANCE by Abbe D Lowell appearing for Gary D Osborn, Apothecure Inc. (ctf) (Entered: 07/17/2012)

Friday, June 22, 2012

United States Supreme Court Decision Should Apply to Fine in Gary Osborn's case


The United States Supreme Court issued a rule in Southern Union v. United States that should apply to Gary Osborn's recent motion filed. By a vote of six to three, the Court reversed the decision of the First Circuit and remanded the case for further consideration. The Court held that the rule established in Apprendi v. New Jersey.  In Apprendi, the Court held that the Sixth Amendment’s jury-trial guarantee requires that any fact (other than the fact of a prior conviction) which increases the maximum punishment authorized for a particular crime be proved to a jury beyond a reasonable doubt.  In Southern Union, the Court held that the rule in Apprendi applies to the imposition of criminal fines. 

To read previous post, click here.